Leuprorelin acetate Prescribing at MARKET SURGERY
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
86
Total Quantity
90
NHS Cost
£17.6K
vs National Avg
+85.6%
MARKET SURGERY prescribed 86 items of Leuprorelin acetate over the last 12 months at a cost of £17,642 to the NHS. This is 85.6% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
14
Jun 2026
13
Jun 2026
3
Jun 2026
7
Jun 2026
9
Jun 2026
3
Jun 2026
8
Jun 2026
7
Jun 2026
8
Jun 2026
5
Jun 2026
9
Prescribing Details
| Total Items | 86 |
|---|---|
| Total Quantity | 90 |
| Total NHS Cost | £17,642 |
| Presentations | 3 different forms |
| vs National Average | +85.6% |
Leuprorelin acetate Prescribing Comparison
| This practice | 86 items |
|---|---|
| National average per practice | 46 items |
| Difference | +85.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.